Publicacións nas que colabora con Jesús Miguel García-Foncillas López (192)

2021

  1. Early imaging and molecular changes with neoadjuvant bevacizumab in stage ii/iii breast cancer

    Cancers, Vol. 13, Núm. 14

  2. Overcoming PLK1 inhibitor resistance by targeting mevalonate pathway to impair AXL-TWIST axis in colorectal cancer

    Biomedicine and Pharmacotherapy, Vol. 144

2020

  1. Strong Antitumor Activity of Bevacizumab and Aflibercept in Neuroendocrine Carcinomas: In-Depth Preclinical Study

    Neuroendocrinology, Vol. 110, Núm. 1-2, pp. 50-62

  2. Targeting Galectin-1 by Aflibercept Strongly Enhances Its Antitumor Effect in Neuroendocrine Carcinomas

    Neuroendocrinology, Vol. 111, Núm. 1-2, pp. 146-157

2019

  1. Author Correction: Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer (Scientific Reports, (2019), 9, 1, (2589), 10.1038/s41598-019-39291-2)

    Scientific Reports

  2. Breast implant-associated anaplastic large-cell lymphoma. Consensus document part II: Staging, prognosis and follow-up

    Revista de Senologia y Patologia Mamaria, Vol. 32, Núm. 2, pp. 67-74

  3. Breast-implant associated anaplastic large-cell lymphoma. Consensus document (I). Epidemiology, pathogenesis, symptoms and diagnosis

    Revista de Senologia y Patologia Mamaria, Vol. 32, Núm. 2, pp. 61-66

  4. Combination of KIR2DS4 and FcγRIIa polymorphisms predicts the response to cetuximab in KRAS mutant metastatic colorectal cancer

    Scientific Reports, Vol. 9, Núm. 1

  5. Prognostic significance of neutrophil-to lymphocyte ratio and platelet-to lymphocyte ratio in older patients with metastatic colorectal cancer

    Journal of Geriatric Oncology, Vol. 10, Núm. 5, pp. 742-748

  6. UNR/CSDE1 expression is critical to maintain invasive phenotype of colorectal cancer through regulation of c-MYC and epithelial-to-mesenchymal transition

    Journal of Clinical Medicine, Vol. 8, Núm. 4

2018

  1. Laparoscopic paraaortic surgical staging in locally advanced cervical cancer: a single-center experience

    Clinical and Translational Oncology, Vol. 20, Núm. 11, pp. 1455-1459

  2. The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer

    BMC Cancer, Vol. 18, Núm. 1

2017

  1. Functional PTGS2 polymorphism-based models as novel predictive markers in metastatic renal cell carcinoma patients receiving first-line sunitinib

    Scientific Reports, Vol. 7

  2. UNR/CDSE1 expression as prognosis biomarker in resectable pancreatic ductal adenocarcinoma patients: A proof-of-concept

    PLoS ONE, Vol. 12, Núm. 8

2016

  1. Decreased PLK1 expression denotes therapy resistance and unfavourable disease-free survival in rectal cancer patients receiving neoadjuvant chemoradiotherapy

    Pathology Research and Practice, Vol. 212, Núm. 12, pp. 1133-1137

  2. Focal adhesion kinase: predictor of tumour response and risk factor for recurrence after neoadjuvant chemoradiation in rectal cancer

    Journal of Cellular and Molecular Medicine, Vol. 20, Núm. 9, pp. 1729-1736

  3. PLK-1 Expression is Associated with Histopathological Response to Neoadjuvant Therapy of Hepatic Metastasis of Colorectal Carcinoma

    Pathology and Oncology Research, Vol. 22, Núm. 2, pp. 377-383

  4. Predictive value of vrk 1 and 2 for rectal adenocarcinoma response to neoadjuvant chemoradiation therapy: A retrospective observational cohort study

    BMC Cancer, Vol. 16, Núm. 1

  5. Vitamin C uncouples the Warburg metabolic switch in KRAS mutant colon cancer

    Oncotarget, Vol. 7, Núm. 30, pp. 47954-47965

2015

  1. Analysis of BRCA1 and mtDNA haplotypes and mtDNA polymorphism in familial breast cancer

    Mitochondrial DNA, Vol. 26, Núm. 2, pp. 227-231